Skip to main content

Table 4 Protective efficacy of the 14 single clones in the fourth round of cDNA expression library screening

From: Identification of immune protective genes of Eimeria maxima through cDNA expression library screening

Group

Average body-weight gain (g)

Relative body-weight gain (%)

Mean lesion scores

Decreased oocyst output (%)

ACI

Unchallenged control

57.61 ± 9.47f

100

0 ± 0a

100.00

200

Challenged control

36.89 ± 11.89ab

63.68

2.63 ± 0.63fg

0.00

97.30

pVAX1 control

37.42 ± 6.82abc

60.29

1.80 ± 0.38cdef

8.91

102.24

Clone 8–2–2–1

41.76 ± 18.49abcde

69.09

2.81 ± 1.50g

56.44

130.97

Clone 8–2–2–2

48.83 ± 12.79cdef

81.12

0.81 ± 0.62b

51.49

162.97

Clone 8–2–2–3

40.12 ± 13.95abcd

64.47

2.36 ± 1.24defg

13.86

100.79

Clone 8–2–2–4

43.26 ± 14.30abcde

73.50

2.84 ± 1.21g

14.85

105.08

Clone 8–2–2–5

56.63 ± 26.03f

93.89

1.66 ± 0.93bcde

56.44

167.21

Clone 8–2–2–6

38.82 ± 11.68abcd

63.52

1.92 ± 1.32cdef

23.76

104.31

Clone 8–2–2–7

39.88 ± 18.61abcd

66.43

2.78 ± 1.42g

18.81

98.54

Clone 8–2–8–1

50.04 ± 19.32def

84.86

1.26 ± 0.92bc

52.48

162.22

Clone 8–2–8–2

48.27 ± 16.57bcdef

80.03

1.50 ± 1.31bcd

82.18

160.02

Clone 8–2–8–3

49.52 ± 18.54def

85.80

1.57 ± 1.75bcd

72.28

160.02

Clone 8–2–8–4

34.84 ± 14.24a

60.28

1.52 ± 1.24bcd

15.84

105.02

Clone 8–2–8–5

46.87 ± 12.41bcdef

82.19

1.47 ± 1.19bc

66.34

157.46

Clone 8–2–8–6

52.41 ± 15.10ef

89.07

1.83 ± 1.24cdef

60.40

160.74

Clone 8–2–8–7

39.89 ± 11.89abcd

68.08

2.46 ± 1.14efg

35.64

123.40

  1. Note: Significant difference (P < 0.05) between numbers with different letters; non-significant difference (P > 0.05) between numbers with the same letter